[1]
Acuña Ortega, N. et al. 2026. Case series of desensitization to pegylated escherichia coli–derived asparaginase: An effective option in response to the need. Allergologia et Immunopathologia. 54, 4 (Jul. 2026), 128–131. DOI:https://doi.org/10.15586/.